STOCK-BASED COMPENSATION (Details) $ in Thousands |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|---|
|
Mar. 31, 2022
USD ($)
director
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2021
USD ($)
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2021
USD ($)
|
|
| Stock-based compensation expense related to stock-based awards | |||||
| Total stock-based compensation expense | $ 2,707 | $ 2,202 | $ 8,305 | $ 7,147 | |
| Extended exercise period, number of members of Board of Directors | director | 2 | ||||
| Incremental stock-based compensation expense | $ 800 | ||||
| Selling, general and administrative | |||||
| Stock-based compensation expense related to stock-based awards | |||||
| Total stock-based compensation expense | 2,119 | 1,800 | 6,791 | 5,625 | |
| Research and development expense | |||||
| Stock-based compensation expense related to stock-based awards | |||||
| Total stock-based compensation expense | $ 588 | $ 402 | $ 1,514 | $ 1,522 | |
| X | ||||||||||
- Definition Represents the number of members of the board of directors for which exercise period has been extended. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition An excess of the fair value of the modified award over the fair value of the award immediately before the modification. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|